4//SEC Filing
BASTA JAMES 4
Accession 0000950170-24-025906
CIK 0001652130other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
8.7 KB
Accession
0000950170-24-025906
Insider Transaction Report
Form 4
BASTA JAMES
EVP, General Counsel
Transactions
- Award
Common Stock
2024-03-01+32,394→ 83,868 total - Sale
Common Stock
2024-03-04$32.99/sh−2,297$75,778→ 81,571 total - Award
Stock Option (right to buy)
2024-03-01+46,752→ 46,752 totalExercise: $32.66Exp: 2034-02-28→ Common Stock (46,752 underlying)
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2024, and does not represent a volitional trade by the Reporting Person.
- [F3]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001792726
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:10 PM ET
- Size
- 8.7 KB